Description of impactBased on my research the British Society for Antimicrobial Chemotherapy have published a new national guideline for the assessment of children with possible invasive meningococcal disease.
Who is affectedAll children with fever and a non-blanching rash in the UK
NarrativeThe Petechiae in Children study was the largest ever study of fever and non-blanching rashes performed. Including over 1300 children from 37 UK hospitals it represents the best evidence for the management of this high risk group. The findings from this research have been translated into new national guidance. This will impact thousands of children every year. It will result in fewer children having their meningococcal infection missed. It will also result in fewer admissions to hospital and better antimicrobial stewardship.
|Impact date||30 Sep 2016|
|Category of impact||Health Impact|
Documents & Links
Validating clinical practice guidelines for the management of children with non-blanching rashes in the UK (PiC) a prospective, multicentre cohort study
Research output: Contribution to journal › Article › peer-review